Ignite Creation Date:
2024-05-05 @ 11:45 AM
Last Modification Date:
2024-10-26 @ 9:12 AM
Study NCT ID:
NCT00120874
Status:
COMPLETED
Last Update Posted:
2016-10-25
First Post:
2005-07-12
Brief Title:
Memantine and Comprehensive Individualized Management of Alzheimers Disease and Caregiver Training
Sponsor:
NYU Langone Health
Organization:
NYU Langone Health
Study Overview
Official Title:
Memantine and Comprehensive Individualized Patient Centered Management of Alzheimers Disease A Randomized Controlled Trial
Status:
COMPLETED
Status Verified Date:
2016-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to determine whether a comprehensive individualized management approach with caregiver training and medication with memantine will alleviate symptoms in community dwelling patients with moderate to severe Alzheimers disease
Detailed Description:
Presently some 45 million people are afflicted with Alzheimers disease in the United States At present pharmacologic treatment although beneficial is not curative Certain nonpharmacologic treatments have assisted caregivers of AD patients by reducing their stress and burden and others have aided patients by improving their mood and physical functioning Comprehensive individualized approaches to improving Alzheimers patients symptomatology and caregiver stress and burden have not been systematically investigated in Alzheimers patient care This study seeks to train and counsel caregivers as well as develop an individualized comprehensive management program that will seek to enhance the functioning of each patient participant
Patients are randomly placed into one of two groups Both groups receive memantine and comprehensive evaluations at baseline 4 1228 and 52 weeks Additionally group 1 receives an individualized management program which consists of home visits to get the patient exercising doing enjoyable activities and cognitive stimulation educational sessions for caregivers on coping with difficult situations and a caregiver support group to help with questions and emotional concerns
Patients are randomly placed into one of two groups Both groups receive memantine and comprehensive evaluations at baseline 4 1228 and 52 weeks Additionally group 1 receives an individualized management program which consists of home visits to get the patient exercising doing enjoyable activities and cognitive stimulation educational sessions for caregivers on coping with difficult situations and a caregiver support group to help with questions and emotional concerns
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| NAM MD 18 | OTHER_GRANT | Forest Laboratories | None |